Immunocore Holdings plc (IMCR)
↓ Download CSV- Sector Manufacturing
- Incorporated X0
- Fiscal year ends Dec 31
In fiscal 2025, Immunocore Holdings plc reported revenue of $400.02M, up 29.0% from the prior year. The company ran a net loss, with a net margin of -8.9%. It held $1.07B in total assets against $686.24M in total liabilities.
Key ratios (FY2025)
-11.3%
Operating margin
-8.9%
Net margin
-9.3%
Return on equity
+29.0%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Revenue | $400.02M | $310.20M | $249.43M | $174.36M | $4.08M | — |
| Cost of Revenue | $5.09M | $2.73M | $1.04M | $1.09M | $0 | — |
| Operating Income | -$45.35M | -$70.46M | -$59.65M | -$51.71M | -$174.59M | — |
| Net Income | -$35.51M | -$51.09M | -$55.29M | -$52.54M | -$180.03M | — |
| EPS (Diluted) | $-0.71 | $-1.02 | $-1.13 | $-1.15 | $-4.24 | — |
| Total Assets | $1.07B | $1.01B | $597.00M | $526.76M | — | — |
| Total Liabilities | $686.24M | $648.79M | $228.16M | $187.86M | — | — |
| Shareholders' Equity | $381.03M | $360.72M | $368.84M | $338.90M | $233.71M | $76.91M |
| Cash & Equivalents | $467.71M | $455.73M | $442.63M | $402.47M | — | — |
| Operating Cash Flow | -$10.71M | $26.06M | $2.94M | -$49.21M | -$143.11M | — |
| Capital Expenditures | $4.34M | $5.17M | $5.42M | $2.20M | $1.39M | — |
| Shares Outstanding | 50.35M | 49.99M | 48.89M | 45.71M | 42.49M | — |
| Dividends Per Share | $0.00 | $0.00 | $0.00 | $0.00 | — | — |